Correlation between soluble intercellular adhesion molecule 1 level and extracellular superoxide dismutase activity in rheumatoid arthritis: a possible association with disease activity-Reference-Cited by-同舟云学术

Correlation between soluble intercellular adhesion molecule 1 level and extracellular superoxide dismutase activity in rheumatoid arthritis: a possible association with disease activity

Published:2004-07 Issue:4 Volume:33 Page:239-243
ISSN:0300-9742
Container-title:Scandinavian Journal of Rheumatology
language:en
Short-container-title:Scandinavian Journal of Rheumatology

Author:

Ugur M,Yildirim K,Kiziltunc A,Erdal A,Karatay S,Senel K

Publisher

Informa UK Limited

Subject

Immunology,General Medicine,Immunology and Allergy,Rheumatology

Link

http://www.tandfonline.com/doi/pdf/10.1080/03009740310004054

Reference29 articles.

1. The adhesion molecules of inflammation

2. Leukocyte-endothelial cell interaction and the control of leukocyte migration into inflamed synovium

3. Adhesion receptors of the immune system

4. Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Superoxide dismutase: an updated review on its health benefits and industrial applications;Critical Reviews in Food Science and Nutrition;2021-04-27

2. The predictive value of serum soluble ICAM-1 and CXCL13 in the therapeutic response to TNF inhibitor in rheumatoid arthritis patients who are refractory to csDMARDs;Clinical Rheumatology;2020-03-23

3. The dynamic uptake and release of SOD3 from intracellular stores in macrophages modulates the inflammatory response;Redox Biology;2019-09

4. Cell adhesion molecules and plasminogen activator inhibitor type-1 (PAI-1) in patients with rheumatoid arthritis: influence of metabolic syndrome;Clinical and Experimental Medicine;2018-07-14

5. Protective effect of higenamine ameliorates collagen-induced arthritis through heme oxygenase-1 and PI3K/Akt/Nrf-2 signaling pathways;Experimental and Therapeutic Medicine;2016-09-20